Mercator Medical (FRA:MM2) YoY EPS Growth: -54.73% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:MM2 Mercator Medical SA FRA:MM2
57 GF Score
Price €12.70
GF Value €11.46
! 6 Warning Signs
View Full Analysis

What is Mercator Medical YoY EPS Growth?

Mercator Medical FRA:MM2 +0.32% 57 YoY EPS Growth is -54.73% as of Mar. 2026. GuruFocus rates FRA:MM2 with a GF Score™ of 57/100 and a GF Value™ of €11.46. The stock has 6 warning signs investors should review.

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Mercator Medical's YoY EPS Growth for the quarter that ended in Mar. 2026 was -54.73%.

Mercator Medical's Earnings per Share (Diluted) for the three months ended in Mar. 2026 was €0.34.

Mercator Medical YoY EPS Growth Historical Data

* Premium members only.

The historical data trend for Mercator Medical's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mercator Medical YoY EPS Growth Chart

Mercator Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -50.02 -143.97 89.44 331.87 -34.72

Mercator Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 167.15 -57.72 116.94 -95.65 -54.73
FRA:MM2
57GF Score
Mercator Medical SA FRA:MM2
YoY EPS Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mercator Medical YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Mercator Medical's YoY EPS Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EPS Growth (A: Dec. 2025 )
=(Earnings per Share (Diluted) (A: Dec. 2025 )-Earnings per Share (Diluted) (A: Dec. 2024 ))/ | Earnings per Share (Diluted) (A: Dec. 2024 ) |
=(0.722-1.106)/ | 1.106 |
=-34.72 %

Mercator Medical's YoY EPS Growth for the quarter that ended in Mar. 2026 is calculated as:

YoY EPS Growth (Q: Mar. 2026 )
=(Earnings per Share (Diluted) (Q: Mar. 2026 )-Earnings per Share (Diluted) (Q: Mar. 2025 )) / | Earnings per Share (Diluted) (Q: Mar. 2025 )) |
=(0.335-0.74)/ | 0.74 |
=-54.73 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EPS Growth →
What does a YoY EPS Growth of -54.73% mean?
Mercator Medical (FRA:MM2) has a YoY EPS Growth of -54.73% as of Mar. 2026. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Mercator Medical and its competitors.
Is Mercator Medical's YoY EPS Growth too high?
Mercator Medical's current YoY EPS Growth is -54.73%. Overall, Mercator Medical has a GF Score™ of 57/100, reflecting its overall financial health beyond just this single metric.
How does Mercator Medical's YoY EPS Growth compare to ISRG and BDX?
Mercator Medical's YoY EPS Growth of -54.73% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EPS Growth for a Medical Devices & Instruments company?
A good YoY EPS Growth depends on the Medical Devices & Instruments industry context. However, YoY EPS Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EPS Growth mean?
A high YoY EPS Growth can signal that a stock is expensive relative to its fundamentals. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Mercator Medical and its competitors. Mercator Medical's current YoY EPS Growth is -54.73%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mercator Medical stock overvalued right now?
Mercator Medical (FRA:MM2) has a current YoY EPS Growth of -54.73%. The stock's GF Value™ is €11.46, compared to a current price of €12.70 — trading 10.8% above its estimated fair value. The current YoY EPS Growth is -54.73%. Mercator Medical's overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EPS Growth calculated?
YoY EPS Growth is calculated from a company's financial statements. For Mercator Medical (FRA:MM2), the current YoY EPS Growth is -54.73% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mercator Medical (FRA:MM2) Overvalued in 2026?

Based on GuruFocus' analysis, Mercator Medical stock appears to be overvalued. The current stock price of €12.70 is trading 10.8% above its estimated GF Value™ of €11.46.

Key valuation signals for FRA:MM2:

  • YoY EPS Growth: -54.73%
  • GF Value™: €11.46 vs. price of €12.70 (10.8% above fair value)
  • GF Score™: 57/100 with 6 warning signs

No single metric tells the full story. See the FRA:MM2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mercator Medical Business Description

Other Exchanges MRC:Poland
Address Ulica H. Modrzejewska 30, Krakow, POL, 31-327
Mercator Medical SA produces and sells medical gloves and distributor of medical disposables. The company's products - mainly gloves, dressings, disposable clothing and surgical drapes. It operates in Europe and Russia.
57GF Score

Get the complete analysis for FRA:MM2

YoY EPS Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.70
Price
€11.46
GF Value